Efficacy and Safety of LAS 34273 in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease(COPD)
NCT ID: NCT00358436
Last Updated: 2017-01-04
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
804 participants
INTERVENTIONAL
2006-08-31
2008-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)
NCT00363896
Efficacy, Safety, and Tolerability of Aclidinium Bromide in the Treatment of Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-38)
NCT01045161
Efficacy and Safety of Aclidinium Bromide for Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-33)
NCT00891462
A Study of Exercise Endurance and Lung Hyperinflation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
NCT00500318
Long-term Safety, Tolerability and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-35)
NCT01044459
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Aclidinium 200 μg once-daily
Aclidinium bromide 200 μg once-daily by inhalation
Aclidinium bromide
Aclidinium bromide 200 μg once-daily via inhalation by the Eklira Genuair® inhaler: 1 puff in the morning for 52 weeks
Placebo
Placebo by inhalation
Placebo
Placebo once-daily via inhalation: 1 puff in the morning for 52 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aclidinium bromide
Aclidinium bromide 200 μg once-daily via inhalation by the Eklira Genuair® inhaler: 1 puff in the morning for 52 weeks
Placebo
Placebo once-daily via inhalation: 1 puff in the morning for 52 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Esther Garcia, MD
Role: STUDY_DIRECTOR
AstraZeneca
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Almirall Investigational Sites#926
Jasper, Alabama, United States
Almirall Investigational Sites#858
Ozark, Alabama, United States
Almirall Investigational Sites#900
Phoenix, Arizona, United States
Almirall Investigational Sites#899
Tucson, Arizona, United States
Almirall Investigational Sites#855
Tucson, Arizona, United States
Almirall Investigational Sites#879
Little Rock, Arkansas, United States
Almirall Investigational Sites#932
Carmichael, California, United States
Almirall Investigational Sites#904
Encinitas, California, United States
Almirall Investigational Sites#903
Fullerton, California, United States
Almirall Investigational Sites#930
Los Angeles, California, United States
Almirall Investigational Sites#922
Los Angeles, California, United States
Almirall Investigational Sites#893
North Hills, California, United States
Almirall Investigational Sites#871
Rancho Mirage, California, United States
Almirall Investigational Sites#902
Riverside, California, United States
Almirall Investigational Sites#850
San Diego, California, United States
Almirall Investigational Sites#897
San Diego, California, United States
Almirall Investigational Sites#924
Torrance, California, United States
Almirall Investigational Sites#882
Walnut Creek, California, United States
Almirall Investigational Sites#895
Denver, Colorado, United States
Almirall Investigational Sites#880
Fort Collins, Colorado, United States
Almirall Investigational Sites#888
Wheat Ridge, Colorado, United States
Almirall Investigational Sites#952
Waterbury, Connecticut, United States
Almirall Investigational Sites#844
Bay Pines, Florida, United States
Almirall Investigational Sites#863
Clearwater, Florida, United States
Almirall Investigational Sites#152
DeLand, Florida, United States
Almirall Investigational Sites#8533
Melbourne, Florida, United States
Almirall Investigational Sites#920
Tamarac, Florida, United States
Almirall Investigational Sites#894
Tampa, Florida, United States
Almirall Investigational Sites#889
Tampa, Florida, United States
Almirall Investigational Sites#890
Atlanta, Georgia, United States
Almirall Investigational Sites#907
Decatur, Georgia, United States
Almirall Investigational Sites#931
Gainesville, Georgia, United States
Almirall Investigational Sites#849
Marietta, Georgia, United States
Almirall Investigational Sites#933
Chicago, Illinois, United States
Almirall Investigational Sites#872
Hines, Illinois, United States
Almirall Investigational Sites#892
River Forest, Illinois, United States
Almirall Investigational Sites#864
Evansville, Indiana, United States
Almirall Investigational Sites#876
Bowling Green, Kentucky, United States
Almirall Investigational Sites#923
Florence, Kentucky, United States
Almirall Investigational Sites#866
Lafayette, Louisiana, United States
Almirall Investigational Sites#911
Shreveport, Louisiana, United States
Almirall Investigational Sites#883
Biddeford, Maine, United States
Almirall Investigational Sites#976
Lewiston, Maine, United States
Almirall Investigational Sites#843
Baltimore, Maryland, United States
Almirall Investigational Sites#868
Cadillac, Michigan, United States
Almirall Investigational Sites#884
Minneapolis, Minnesota, United States
Almirall Investigational Sites#916
Saint Charles, Missouri, United States
Almirall Investigational Sites#906
Butte, Montana, United States
Almirall Investigational Sites#909
Omaha, Nebraska, United States
Almirall Investigational Sites#846
Cherry Hill, New Jersey, United States
Almirall Investigational Sites#885
Newark, New Jersey, United States
Almirall Investigational Sites#921
Summit, New Jersey, United States
Almirall Investigational Sites#896
Albuquerque, New Mexico, United States
Almirall Investigational Sites#861
Chapel Hill, North Carolina, United States
Almirall Investigational Sites#919
Charlotte, North Carolina, United States
Almirall Investigational Sites#878
Elizabeth City, North Carolina, United States
Almirall Investigational Sites#842
Williamston, North Carolina, United States
Almirall Investigational Sites#915
Winston-Salem, North Carolina, United States
Almirall Investigational Sites#848
Cincinnati, Ohio, United States
Almirall Investigational Sites#870
Cincinnati, Ohio, United States
Almirall Investigational Sites#847
Columbus, Ohio, United States
Almirall Investigational Sites#928
Sylvania, Ohio, United States
Almirall Investigational Sites#905
Eugene, Oregon, United States
Almirall Investigational Sites#860
Medford, Oregon, United States
Almirall Investigational Sites#886
Medford, Oregon, United States
Almirall Investigational Sites#910
Charleston, South Carolina, United States
Almirall Investigational Sites#918
Greer, South Carolina, United States
Almirall Investigational Sites#898
Dallas, Texas, United States
Almirall Investigational Sites#854
Fort Worth, Texas, United States
Almirall Investigational Sites#875
Houston, Texas, United States
Almirall Investigational Sites#881
San Antonio, Texas, United States
Almirall Investigational Sites#951
Richmond, Virginia, United States
Almirall Investigational Sites#856
Milwaukee, Wisconsin, United States
Almirall Investigational Sites#800
Buenos Aires, , Argentina
Almirall Investigational Sites#744
Buenos Aires, , Argentina
Almirall Investigational Sites#792
Buenos Aires, , Argentina
Almirall Investigational Sites#793
Buenos Aires, , Argentina
Almirall Investigational Sites#799
Buenos Aires, , Argentina
Almirall Investigational Sites#795
Buenos Aires, , Argentina
Almirall Investigational Sites#801
Buenos Aires, , Argentina
Almirall Investigational Sites#791
Buenos Aires, , Argentina
Almirall Investigational Sites#797
El Palomar, , Argentina
Almirall Investigational Sites#740
La Plata, , Argentina
Almirall Investigational Sites#801
Rosario, , Argentina
Almirall Investigational Sites#796
San Miguel de Tucumán, , Argentina
Almirall Investigational Sites#794
Vicente López, , Argentina
Almirall Investigational Sites#807
Adelaide, , Australia
Almirall Investigational Sites#834
Auchenflower, , Australia
Almirall Investigational Sites#808
Bankstown, , Australia
Almirall Investigational Sites#806
Boxhill, , Australia
Almirall Investigational Sites#814
Cairns, , Australia
Almirall Investigational Sites#813
Camperdown, , Australia
Almirall Investigational Sites#811
Carina Heights, , Australia
Almirall Investigational Sites#803
Clayton, , Australia
Almirall Investigational Sites#809
Kippa-Ring, , Australia
Almirall Investigational Sites#8121
Nedlands, , Australia
Almirall Investigational Sites#812
Nedlands, , Australia
Almirall Investigational Sites#805
Toorak Gardens, , Australia
Almirall Investigational Sites#815
Woodville, , Australia
Almirall Investigational Sites#823
Edmonton, , Canada
Almirall Investigational Sites#818
Kelowna, , Canada
Almirall Investigational Sites#822
Montreal, , Canada
Almirall Investigational Sites#817
Niagara Falls, , Canada
Almirall Investigational Sites#821
Ottawa, , Canada
Almirall Investigational Sites#935
Ottawa, , Canada
Almirall Investigational Sites#820
Toronto, Ontario, , Canada
Almirall Investigational Sites#827
Monterrey, , Mexico
Almirall Investigational Sites#826
Zapopan, , Mexico
Almirall Investigational Sites#936
Auckland, , New Zealand
Almirall Investigational Sites#830
Grafton, , New Zealand
Almirall Investigational Sites#832
Tauranga, , New Zealand
Almirall Investigational Sites#836
Bloemfontain, , South Africa
Almirall Investigational Sites#841
Bloemfontein, , South Africa
Almirall Investigational Sites#839
Cape Town, , South Africa
Almirall Investigational Sites#835
Cape Town, , South Africa
Almirall Investigational Sites#837
Cape Town, , South Africa
Almirall Investigational Sites#840
Cape Town, , South Africa
Almirall Investigational Sites#834
Durban, , South Africa
Almirall Investigational Sites#833
eManzimtoti, , South Africa
Almirall Investigational Sites#838
Johannesburg, , South Africa
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Jones PW, Rennard SI, Agusti A, Chanez P, Magnussen H, Fabbri L, Donohue JF, Bateman ED, Gross NJ, Lamarca R, Caracta C, Gil EG. Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease. Respir Res. 2011 Apr 26;12(1):55. doi: 10.1186/1465-9921-12-55.
Related Links
Access external resources that provide additional context or updates about the study.
Sponsor web site
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ACCLAIM II
Identifier Type: OTHER
Identifier Source: secondary_id
CT000742
Identifier Type: OTHER
Identifier Source: secondary_id
M/34273/31
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.